Tripada Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 19-12-2024
- Paid Up Capital ₹ 4.50 M
as on 19-12-2024
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.03 Cr
as on 19-12-2024
- Revenue %
(FY 2022)
- Profit -277.91%
(FY 2022)
- Ebitda -329.82%
(FY 2022)
- Net Worth -24.88%
(FY 2022)
- Total Assets
About Tripada Bio-Tech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 4.50 M.
The company has closed loans amounting to ₹2.03 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hasmukhlal Modi, Naynaben Modi, Jignasha Modi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24232GJ2002PTC040533
- Company No.
040533
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tripada Bio-Tech?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hasmukhlal Modi  | Director | 11-Mar-2002 | Current |
| Naynaben Modi | Director | 11-Mar-2002 | Current |
| Jignasha Modi | Director | 11-Mar-2002 | Current |
| Jagrutiben Modi | Director | 11-Mar-2002 | Current |
| Ashaben Modi | Director | 11-Mar-2002 | Current |
| Manjulaben Modi | Director | 11-Mar-2002 | Current |
Financial of Tripada Bio-Tech.
Tripada Bio-Tech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 277.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tripada Bio-Tech?
Unlock access to Tripada Bio-Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 May 2013 | ₹7.50 M | Satisfied |
Hdfc Bank Limited Creation Date: 24 Apr 2013 | ₹6.00 M | Satisfied |
Punjab National Bank Creation Date: 01 Dec 2009 | ₹5.30 M | Satisfied |
How Many Employees Work at Tripada Bio-Tech?
Tripada Bio-Tech has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tripada Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tripada Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
